Medicare Price Negotiation Process Could Adapt Private Sector ‘Best Practices,’ Official Suggests

The Centers for Medicare and Medicaid Services will look to the private sector for guidance on building a Medicare price negotiation process for drugs if legislation establishing such a program is enacted, CMS principal deputy administrator and chief operating officer Jonathan Blum said during a discussion at the Biopharma Virtual Congress co-produced by Prevision Policy and the Friends of Cancer Research.

“What Congress will be asking CMS to do is develop a brand-new skill set,” Blum observed during a session taped on 7 December. “In today’s world, CMS pretty much never negotiates for a price